Boston Scientific Corporation

07/21/2021 | Press release | Distributed by Public on 07/21/2021 05:14

Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX™ Left Atrial Appendage Closure Device